The injectable GHK-Cu peptide has some promising science, but its currently not approved for systemic use by the FDA
Avances en el tratamiento de la Obesidad: Frmacos innovadores para la reduccin de peso que imitan hormonas de la saciedad Estos medicamentos no solo prometen una reduccin efectiva del peso, sino que tambin ofrecen una nueva esperanza para mantener los resultados a largo plazo y evitar las enfermedades asociadas a la obesidad La obesidad, a menudo llamada la pandemia silenciosa del siglo XXI, contina expandindose a un ritmo alarmante a nivel mundial
This Phase 2 trial enrolls participants who meet DSM-5 criteria for moderate to severe AUD and tracks changes in heavy drinking days, total alcohol consumption, and self-reported craving intensity over a 24-week treatment period
Be honest about any weight loss you've experienced, recent dose changes, or side effects you've noticed
Of interest is the observation that exenatide exerts neuro-protective effects in animal and clinical studies of Alzheimers disease
